Jobs
-
Theravance Biopharma said that a Phase 1 study of its TD-0903 nebulized JAK inhibitor is now underway. Earlier this month, Theravance announced that it intended to begin clinical development of TD-0903 for the prevention of… Read more . . .
-
Intranasal vaccine developer BlueWillow Biologics has announced the appointment of Chad Costley as Chief Medical Officer. Costley, an Atlanta-based primary care physician, has previously served on BlueWillow’s board of directors. BlueWillow, formerly known as NanoBio, has a… Read more . . .
-
The FDA has approved an Aurobindo ANDA for generic albuterol (salbutamol) sulfate inhalation solution and, while the agency did not issue a press release, the news was included in the FDA’s COVID-19 “Daily Roundup” and… Read more . . .
-
Aptar has announced a new collaboration agreement with Chinese connected drug delivery specialist Sonmol for development of an inhaler monitoring system designed to “enable remote patient monitoring, improve patient and physician interactions, increase patient engagement… Read more . . .
-
With the transformation of RDD 2020 into Digital RDD 2020 due to the COVID-19 pandemic, one of the biggest questions has been whether previously booked exhibitors would still choose to participate in the technology exhibition.… Read more . . .
-
3P Innovation’s Fill2Weight powder micro-dosing system, which was designed specifically for filling dry powder inhalation formulations, has been awarded the Queen’s Award for Enterprise in Innovation. The Fill2Weight technology is scalable and can be used… Read more . . .
-
Adherium has announced a strategic partnership with Australian tech company Planet Innovation for device hardware and software development related to Adherium’s inhaler monitoring systems. According to the company, the new deal is “complementary” to the… Read more . . .
-
The University of Waterloo has announced that School of Pharmacy faculty members Roderick Slavcev and Emmanuel Ho are collaborating with Chemical Engineering professor Marc Aucoin on development of an intranasal vaccine against COVID-19. According to… Read more . . .
-
US-based Enterin Inc. announced that it has been in talks with the FDA in preparation for a Phase 1/2a study of a nebulized formulation of its COV-ENT-1 in patients hospitalized with COVID-19. The company said that… Read more . . .
-
According to Beyond Air, the company has received permission from the FDA to initiate a clinical study of its LungFit inhaled nitric oxide system for the treatment of COVID-19 patients. The announcement comes almost a month… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland